| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-07 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |